Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AltaValve Early Feasibility Study Protocol

NCT03997305 is registered in ClinicalTrials.gov with 4C Medical Technologies, Inc. as lead sponsor.

NCT NCT03997305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AltaValve Early Feasibility Study Protocol
Lead sponsor
4C Medical Technologies, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
December 4, 2019
Completion date
September 30, 2025
Enrollment
15 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

mitral incompetence, mitral insufficiency, mitral regurgitation, mitral valve incompetence, mitral valve regurgitation